PMA device
CentriMag Circulatory Support System
Abbott · Ventricular (Assist) Bypass (DSQ, Class III) · First FDA decision Dec 6, 2019, newest Dec 1, 2025Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
2
Naming "CentriMag Circulatory Support"
MAUDE reports
0
Brand "CentriMag Circulatory Support", since 2015
PubMed studies
1
Mentioning "CentriMag Circulatory Support"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CentriMag Circulatory Support System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 8 decisions filed under this name.
FDA's records could not be loaded.
Older decisions: P170038-S001, P170038
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CentriMag Circulatory Support", any status and sponsor, newest update first.
- Cardiogenic Shock Working Group RegistryRecruiting
Tufts Medical CenterAcademic, hospital or other
NCT04682483 · 20,000 participants (planned) · Start Dec 4, 2017 · Primary completion Dec 2027
Device: Acute Mechanical Circulatory Support Devices · For: Cardiogenic Shock
Sites: Weston, Florida; Chicago, Illinois; Indianapolis, Indiana · 22 sites in all
Abbott Medical DevicesPublic (ABT)
NCT04464785 · 32 participants · Start Dec 30, 2020 · Primary completion Oct 25, 2024
Device: CentriMag Circulatory Support System · For: Heart Failure
Sites: Little Rock, Arkansas; Atlanta, Georgia; Oak Lawn, Illinois · 8 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CentriMag Circulatory Support", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DSQ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "CentriMag Circulatory Support"[tiab]. The summary above synthesizes these.
- Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure.
John R, Liao K, Lietz K, et al. · J Thorac Cardiovasc Surg · 2007
Other devices of this type
Also filed under product code DSQ.
- HeartWare® Ventricular Assist SystemMedtronic · PMA 2026
- HeartMate 3 Left Ventricular Assist SystemAbbott Medical · PMA 2026
- HeartWare HVAD SystemMedtronic · PMA 2026
- Thoratec Ventricular Assist Device (Vad)Thoratec Laboratories Corp. · PMA 2013
- HeartMate II Left Ventricular Assist SystemAbbott Medical · PMA 2026
- EXCOR Pediatric Ventricular Assist DeviceBerlin Heart, Inc. · PMA 2026
- Thoratec Heartmate II Left Ventricular Assist SystemAbbott Medical · PMA 2017
- Abiomed Bvs 5000 Bi-Ventricular Support SystemAbiomed Cardiovascular, Inc. · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.